All In Biotech

Drug Trial Radar · NCT04551066

To Evaluate the Efficacy and Safety of Parsaclisib and Ruxolitinib in Participants With Myelofibrosis (LIMBER-313)

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Combination of PI3Kδ Inhibitor Parsaclisib and Ruxolitinib in Participants With Myelofibrosis

Last checked: Nov 19, 2026Latest source record: Oct 21, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedResults posted on the registryPivotal-lookingPhase 3. Randomized with 252 participants. This is a heuristic, not a regulatory label.

Status

Terminated

Enrollment

252

Actual

Start

May 24, 2021

Primary completion

Aug 3, 2023

Study completion Nov 25, 2024

Sponsor

Lead sponsor
Incyte CorporationIncyte (INCY)
Sponsor type
Industry
First posted
Sep 16, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of the study is to compare the efficacy of parsaclisib when combined with ruxolitinb versus placebo combined with ruxolitinib in participants with myelofibrosis.

Conditions

  • Myelofibrosis
  • Primary Myelofibrosis
  • Post Essential Thrombocythemia Myelofibrosis
  • Post Polycythemia Vera Myelofibrosis

Interventions

  • parsaclisibDrug

    parsaclisib will be administered QD orally

  • ruxolitinibDrug

    ruxolitinib will be administered BID orally

  • placeboDrug

    placebo will be administered QD orally

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Participants Achieving ≥35% Reduction in Spleen Volume From Baseline to Week 24 as Measured by Magnetic Resonance Imaging [MRI] (or Computed Tomography [CT] Scan in Applicable Participants)Time frame: Baseline; Week 24

Locations

177 sites in 17 countries. Site status is shown where the registry gives one.

  • Alaska Oncology and Hematology

    Anchorage, Alaska

  • Mayo Clinic Rochester

    Phoenix, Arizona

  • Sutter Health Alta Bates Summit Medical Center Absmc Alta Bates Summit Comprehensive Cancer Center

    Berkeley, California

  • CCARE

    Fresno, California

  • California Research Institute (Cri)

    Los Angeles, California

  • UCLA School of Medicine

    Los Angeles, California

  • Scripps Clinic

    San Diego, California

  • Coastal Integrated Cancer Care-Cicc

    San Luis Obispo, California

  • Stamford Hospital-Medical Oncology Hematology

    Stamford, Connecticut

  • Georgetown University

    Washington D.C., District of Columbia

  • Emory University

    Atlanta, Georgia

  • University of Kansas Hospital Authority

    Westwood, Kansas

  • University of Kentucky-Markey Cancer Center

    Lexington, Kentucky

  • Tulane University

    New Orleans, Louisiana

  • Johns Hopkins University

    Baltimore, Maryland

  • Massachusetts General Hospital

    Boston, Massachusetts

  • Midamerica Cancer Care

    Kansas City, Missouri

  • New Jersey Hematology Oncology Associates Llc

    Brick, New Jersey

  • Morristown Medical Center-Atlantic Health System

    Morristown, New Jersey

  • Roswell Park Cancer Institute

    Buffalo, New York

  • Westchester Medical Center Advanced Oncology and Infusion Center

    Hawthorne, New York

  • Mount Sinai School of Medicine

    New York, New York

  • Memorial Sloan Kettering Cancer Center

    New York, New York

  • Montefiore Medical Center

    The Bronx, New York

  • Duke Cancer Center

    Durham, North Carolina

  • Wake Forest Baptist Medical Center

    Winston-Salem, North Carolina

  • Ohio State University

    Columbus, Ohio

  • Kaiser Permanente-Northwest

    Portland, Oregon

  • Oregon Health & Science University

    Portland, Oregon

  • Avera Cancer Institute

    Sioux Falls, South Dakota

  • Texas Oncology-Baylor Sammons Cancer Center

    Dallas, Texas

  • Kelsey Seybold Clinic

    Houston, Texas

  • Houston Methodist Hospital

    Houston, Texas

  • Renovatio Clinical

    Spring, Texas

  • Providence Regional Medical Center Everett

    Everett, Washington

  • Seattle Cancer Care Alliance

    Seattle, Washington

  • Ordensklinikum Linz Gmbh Elisabethinen

    Linz, Austria

  • Universitaetsklinikum St. Poelten

    Saint P�LTEN, Austria

  • Hanusch-Krankenhaus Der Wiener Gebietskrankenkasse

    Vienna, Austria

  • Hanusch-Krankenhaus Wiener Gebietskrankenkasse

    Vienna, Austria

Showing 40 of 177 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.